U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07557953) titled 'A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or Obesity' on April 23.
Brief Summary: The study is testing cagrilintide, a study medicine, to understand how it affects food intake and appetite in people with overweight or obesity. Participants will receive either cagrilintide or placebo, and which treatment participants get is decided by chance. Cagrilintide is the treatment being tested, while placebo looks like the study medicine but does not contain any active medicine. The study will last for about 30 weeks.
Study Start Date: April 28
Study Type: INTERVENTIONAL
Cond...